ロード中...
ERα-targeted endocrine therapy, resistance and the role of GPER
Endocrine therapy is an effective option for the treatment of estrogen receptor alpha (ERα)-positive breast cancers. Unfortunately, a large fraction of women relapse with endocrine-resistant tumors. The presence of constitutively active ERα mutants, found in a subset of relapse tumors, is thought to...
保存先:
| 出版年: | Steroids |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859199/ https://ncbi.nlm.nih.gov/pubmed/31518595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.steroids.2019.108493 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|